期刊文献+

CD146与黑色素瘤相关性的研究进展 被引量:6

Current research situation of correlation between CD146 and melanoma
原文传递
导出
摘要 目的:总结CD146对黑色素瘤多方面生物特征的影响,揭示靶向抑制CD146可能在未来人类黑色素瘤的预防和治疗中发挥作用。方法:应用Medline、PubMed及CNKI期刊全文数据库检索系统,以"CD146和黑色素瘤"为关键词,检索自建库至2012-04的相关文献。纳入标准:1)CD146与黑色素瘤的相关性;2)CD146的结构;3)黑色素瘤的治疗及预后。符合分析的文献31篇。结果:CD146作为最近发现的免疫球蛋白家族成员,对调节黑色素瘤的多种生物学特征有重要作用。CD146虽然不影响体外瘤细胞增殖,但能增强体外瘤细胞的侵袭性、运动性、转移性、黏附性和在裸鼠体内的致瘤性及增加瘤内血管的密度,从而促进黑色素瘤的发生和发展。结论:通过阐述CD146对黑色素瘤多方面的作用,有助于揭示黑色素瘤的发病机制和为研发有效治疗方案提供依据。 OBJECTIVE:To summarize articles related to the effect of CD146 on various biological characteristics of melanoma and reveal the possibility of targeting CD146 in the design of future strategies for the prevention and treatment of human melanoma.METHODS: The related works were searched by 'CD146,melanoma' as Keywords in Medline,PubMed and CNKI database until April 2012.Totally 31 papers were selected and analyzed according to the inclusion criteria as follows:1) the correlation between CD146 and melanoma;2) the construction of CD146;3) the treatment and prognosis of melanoma.RESULTS: CD146 as a recently identified member of immunoglobulin gene superfamily,plays an important role in various biological characteristics of melanoma.Though CD146 does not affect the proliferation of melanoma cells in vitro,it can reinforce the invasion,motion,metastasis,adhesion and tumorigenicity in nude mice,and augment the angiogenesis in vivo or vessel-like tube formation in vitro.CONCLUSTION: The research of the role of CD146 in various biological characteristics of melanoma could reveal nature of melanoma and provide a foundation to develop effective treatments.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第2期157-160,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 CD146/MUC18 黑色素瘤 黏附性 致瘤性 血管新生 综述文献 CD146/MUC18 melanoma adhesion tumorigenicity angiogenesis review literature
  • 相关文献

参考文献31

  • 1Erdei E,Torres SM. A new understanding in the epidemiology of melanoma[J].Expert Review of Anticancer Therapy,2010,(11):1811-1823.
  • 2庞得全,郑维国,胡雷,王慧,庞青松,王平.恶性黑色素瘤预后影响因素的Cox分析[J].山东医药,2011,51(12):89-91. 被引量:8
  • 3刘李登,王宏,向军俭,李丹,杨红宇,邓宁.bFGF单抗与顺铂体外联合抑制黑色素瘤B16细胞增殖效应的研究[J].中华肿瘤防治杂志,2010,17(1):1-4. 被引量:10
  • 4Wu GJ,Wu MWH,Wang C. Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice[J].The Journal of Urology,2011,(04):1504-1512.
  • 5Zhang Y,Zheng C,Zhang J. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146[J].Hybridoma,2008,(05):345-352.doi:10.1089/hyb.2008.0034.
  • 6Ma X,Liu J,Wu J. Synergistic killing effect between vorinostat and target of CD146 in malignant cells[J].Clinical Cancer Research,2010,(21):5165-5176.
  • 7Guezguez B,Vigneron P,Lamerant N. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction:MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor[J].Journal of Immunology,2007,(10):6673-6685.
  • 8Boneberg EM,Illges H,Legler DF. Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calciuminduced,matrix metalloprotease-dependent process[J].Microvascular Research,2009,(03):325-331.
  • 9Bardin N,Blot-Chabaud M,Despoix N. CD146 and its soluble form regulate monocyte transendothelial migration[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2009,(05):746-753.
  • 10杨晓宇,闫振林.胰岛素样生长因子-1受体在恶性黑色素瘤中的表达及临床意义[J].临床误诊误治,2010,23(10):901-903. 被引量:3

二级参考文献63

共引文献52

同被引文献69

  • 1张俊娥,郑美春,苏小茵,李津,叶新梅.社会支持对结肠造口患者自尊变化的影响[J].中华护理杂志,2005,40(7):489-492. 被引量:54
  • 2石少波 ,潘惟华 ,孙丕健 ,曲凤坚 ,范淑贞 ,郭秀英 .血液透析患者心理状况及社会支持的临床研究[J].中国行为医学科学,2005,14(9):784-785. 被引量:25
  • 3Yanyong Kang,Fengcai Wang,Jing Feng,Dongling Yang,Xu Yang,Xiyun Yan.Knockdown of CD146 reduces the migration and proliferation of human endothelial cells[J].Cell Research,2006,16(3):313-318. 被引量:34
  • 4JOHNSON D B, SOSMAN J A. Therapeutic advances and treat- ment options in metastatic melanoma [J]. JAMA Oncol, 2015, 1 (3) : 380-386. DOI: 10. 1001/jamaoncol. 2015. 0565.
  • 5TRINH V A. Current management of metastatic melanoma [ J ]. Am J Health Syst Pharm, 2008, 65 (24 Suppl 9) : $3-$8. DOI: 10.2146/aiho080460.
  • 6CHOHAN T A, QIAN H, PAN Y, et al. Cyclin-dependent kinase-2 as a target for cancer therapy : progress in the development of CDK2 inhibitors as anti-cancer agents [ J ]. Curt Med (]hem, 2015, 22(2) : 237-263. DO1:10. 2174/092986732166 6141106113633.
  • 7ASGHAR U, WITKIEWICZ A K, TURNER N C, et al. The his- tory and future of targeting cyclin-dependent kinases in cancer therapy [J]. Nat Rev Drug Discov, 2015, 14(2): 130-146. DOI : 10. 1038/nrd4504.
  • 8ALEEM E, BERTHET C, KALDIS P. CDK2 as a master of S phase entry: fact or fake? [J]. Cell Cycle, 2004, 3( 1 ) : 35-37. DOI : 10. 4161/cc. 3.1. 632.
  • 9KISZNER G L, WICHMANN B, NEMETH I B, et al. Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas [ J ]. Virchows Arch, 2014, 464 (5): 603-612. DOI: 10. 1007/s00428-014- 1570-1.
  • 10ABDULLAH C I, WANG X, BECKER D. Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma [J]. Cell Cycle, 2011, 10(6): 977-988. DOI:10. 4161/cc. 10.6. 15079.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部